Site menu

Search by ticker code:
Generic filters

Menu

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

CSL Limited (ASX:CSL)

Pharmaceuticals, Biotechnology & Life Sciences

share price: (EoD)

earnings per share:

dividends per share:

CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.

CSL Limited (ASX:CSL) share price

CSL Limited (ASX:CSL) share price news

Experts
Drew Meredith, CFP

June 2020 – ASX 200 market recap

What a month it was for the S&P/ASX 200 (INDEXASX: XJO) and markets more broadly in June 2020, rallying again to cap off the strongest quarter for the ASX in over 20 years.

Today's ASX news
Jaz Harrison

CSL (ASX:CSL) announces an acquisition

CSL (ASX:CSL) has announced an acquisition to the market this morning. It’s called Vitaeris, a clinical-stage biotechnology company.

isignthis-ltd-asx-isx-share-price-boo-down-scary-stink
Editor's picks
Drew Meredith, CFP

S&P/ASX 200 (XJO) tipped to fall, FBR & CSL shares rally

The S&P/ASX 200 (INDEXASX: XJO) is tipped to open slightly lower on Friday with the most popular Sydney Futures Exchange contract pointing to a 14-point decline from yesterday. Here’s what you need to know. 

Skip to content